← Leaderboards
Jayson Michael Rieger
Adenosine Therapeutics, Llc
$2,043,625
Attributed
$2,043,625
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $811.6K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$2,043,625 · 4
By mechanism
R44$1,668,441 · 1
R41$270,401 · 2
R43$104,783 · 1
Top collaborators
No co-investigators on record.
Most similar at Adenosine Therapeutics, Llc
Same institution · by research overlap
- Robert D Thompson$4,905,559
- George Allan Beller$2,554,046
- Shannon P Williams$1,276,772
- William M Scheld$633,055
Others in their field
Top investigators on “Purinergic Receptor”
- Wolfgang G Junger · University Of California San Diego$11,704,048
- Bruce Neil Cronstein · New York University School Of Medicine$10,758,078
- Joel M. Linden · University Of Virginia Charlottesville$9,578,056
- David B Peden · University Of North Carolina Chapel Hill$9,209,178
- Gyorgy Hasko · Univ Of Med/Dent Of Nj-Nj Medical School$9,177,820
- Simon C Robson · Massachusetts General Hospital$7,881,677
Research focus
Purinergic ReceptorDrug Screening /EvaluationAdenosineAdenosine A2a ReceptorAnimalsAntiinflammatory AgentsAmphetaminesBehavioralBinding (Molecular Function)BioavailableBiological AvailabilityBiotechnologyBlood - Brain Barrier AnatomyBlood Vessel ProsthesisCardiovascular Disorder PreventionBrainCerebrospinal FluidCerebrumChemistry, PharmaceuticalChemopreventionClinical TrialsCocaineCollaborationsBase
Grant awards (5)
Adenosine A2A receptor antagonists for the treatment of cocaine addiction$104,783
R43 · FY2007 · DA · contact PI
A2a AR Agonists for Rheumatoid Arthritis$137,603
R41 · FY2006 · AR · contact PI
A2A AR Agonists as Adjunct Therapy Against S. aureus Sepsis$132,798
R41 · FY2006 · AI · contact PI
Novel A2A Adenosine Agonists in Vascular Protection$811,648
R44 · FY2005 · HL
Novel A2A Adenosine Agonists in Vascular Protection$856,793
R44 · FY2004 · HL